IDEX Biometrics ASA
IDEX.OL · OSL
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.31 | -0.00 | 7.82 | 1.60 |
| FCF Yield | -2.17% | -158.89% | -0.07% | -0.10% |
| EV / EBITDA | -17.87 | -0.92 | -1,053.99 | -4,858.07 |
| Quality | ||||
| ROIC | 8.90% | -72.51% | -69.74% | -56.42% |
| Gross Margin | 0.00% | 29.63% | 17.31% | 591.67% |
| Cash Conversion Ratio | 2.59 | 0.71 | 0.66 | 1.51 |
| Growth | ||||
| Revenue 3-Year CAGR | -64.56% | -61.40% | -49.02% | -41.30% |
| Free Cash Flow Growth | -72.10% | 45.14% | 21.69% | -50.32% |
| Safety | ||||
| Net Debt / EBITDA | 1.54 | -0.43 | -0.29 | -0.56 |
| Interest Coverage | -7.84 | -45.45 | -11.84 | -17.33 |
| Efficiency | ||||
| Inventory Turnover | 0.24 | 0.01 | 0.02 | -0.02 |
| Cash Conversion Cycle | 279.49 | 6,827.95 | 5,706.10 | -91.97 |